Presentation by Mr Bobby Richey Deputy Director Biotechnology Group USDA Foreign Agricultural Service Survey of traceability and labeling regimes in other countries
Document Sample


Traceability and Labeling:
A Global Perspective
Bobby Richey
Foreign Agricultural Service/USDA
December 5, 2003
Traceability and Labeling:
A Global Perspective
Key Points
Motivation
Global View
Specific examples
Implications
Key Points
Mandatory biotech traceability and labeling
regimes vary widely
Countries rapidly adopting or considering a
variety of biotech labeling regimes
Many labeling regimes fail to acknowledge
practical implications
Why traceability and labeling?
Traceability:
Market driven
Mandatory
Labeling:
Market driven
Mandatory
Why traceability and labeling?
Economic Interests
Developing countries want to maintain
market access to the EU
Consumer Concerns
EU response to consumer concerns
Japan/Korea respond to consumer demand
but opt for less stringent thresholds, more
practical measures than EU.
Why traceability and labeling?
Environmental Protection
Australia/New Zealand respond to
consumer and environmental concerns
Market Driven vs. Mandatory
U.S. opts for voluntary, market-driven
labeling while EU responds to consumer
demand for mandatory biotech labeling
Sometimes the reasons and
policies are unclear…
China
India
Brazil
Traceability and Labeling
Requirements Worldwide
Country Mandatory Threshold Enforced? Mandatory Biotech
Biotech Labeling? Documentation Required?
Argentina No No (n/a) No
Australia/NZ Yes 1% Yes Yes – to maintain integrity of
labeling regime
Bolivia Yes No No No
Brazil Yes 1% No No
Canada No No (n/a) No
China Yes No Yes, but No
uneven
Colombia Yes No Yes No
Croatia Yes No Yes Yes
Estonia Yes 1% Yes No
EU Yes 1% (0.9% Yes Yes – as of 4/04
as of 4/04)
India No, but considering 1% (n/a) No
Indonesia Yes 5% No No, but considering
Japan Yes 5% Yes Yes – documentation required
for non-biotech labeling
Korea Yes 3% Yes Yes – documentation required
for non-biotech products
(exemption from labeling)
Country Mandatory Threshold Enforced? Mandatory Biotech
Biotech Labeling? Documentation Required?
Malaysia No, but considering No (n/a) No
Mauritius No No (n/a) No, but considering
Poland Yes, to harmonize 1% Yes No, but considering – to
w/EU harmonize w/EU
Romania Yes, to harmonize No (unclear) Yes – to harmonize w/EU
w/EU
Russia Yes 5% No No
Saudi Arabia Yes 1% Yes No
Serbia & Yes, to harmonize 0.9% No Yes - “May contain”
Montenegro w/EU documentation req. for
imports
Slovakia Yes, to harmonize 1% Yes No, but will harmonize w/EU
w/EU regs in future
Sudan No, but considering No (n/a) No, but considering
Taiwan Yes – beginning 5% (n/a) No
1/1/03
Thailand Yes 5% No No
U.S. No No (n/a) No
Vietnam Yes No No No
Zambia No, but considering No (n/a) No
Traceability and Labeling:
A Closer Look
European Union and Accession Countries
Developing Countries
Japan and Korea
Australia and New Zealand
Canada and Argentina
European Union:
Traceability and Labeling Regulations
Mandatory biotech labeling regardless of
detectability, unless identity preserved
Mandatory biotech traceability throughout
the commercial chain
Products Covered
All products produced from biotechnology
including whole grains, food, and feed but
excluding enzymes and processing aids
used in the production.
EU Accession Countries:
Must adopt EU policies as a condition of entry
Countries entering the EU in May 2004
include Cyprus, Czech Republic, Estonia,
Hungary, Latvia, Lithuania, Malta, Poland,
Slovakia, and Slovenia
Potential future members, such as Romania,
Croatia, and Serbia & Montenegro, have or
are planning to harmonize biotech regulations
with the EU.
Developing Countries:
Traceability and Labeling Regulations
Rudimentary or no regulatory systems
Products Covered
Generally unclear what’s covered
Why?
Policies in response to general misinformation/lack
of knowledge about biotech
Lack of ownership of the technology
Lack of risk assessment systems/capacity
External pressures weighing on decision makers
Japan and Korea:
Traceability and Labeling Regulations
Mandatory biotech labeling
3-5 percent labeling threshold
Documentation requirement for non-biotech
Products Covered
Positive product list
Why?
Pressure from consumers
Australia and New Zealand:
Traceability and Labeling Regulations
Mandatory biotech labeling for 1% or more
Use of existing IP/QA system permitted
Products Covered
Across the board – no products specified
Why?
Documentation requirement to maintain
integrity of labeling regime
Canada and Argentina:
Traceability and Labeling Regulations
Mandatory labeling for all products containing
allergens, nutritional changes, or special handling
requirements
No special labeling or product tracing requirements
for biotech products
Products Covered
All products
Why?
General trust in the regulatory system
Codex Discussions of
Traceability or Product Tracing:
Committee on General Principles
Committee on Food Import and Export
Inspection and Certification Systems
Committee on Food Labeling
Ad Hoc Intergovernmental Task Force on
Foods Derived from Biotechnology
Codex Ad Hoc Task Force on Animal Feed
Codex Committee on Methods of Analysis and
Sampling
Effects of Mandatory Biotech
Labeling & Traceability:
Consumer perception potentially skewed
Market uncertainty
Loss of markets
Industry reformulates or re-sources
Increased demands on regulatory systems
Increased producer costs
May force changes in marketing systems
Reduced investment in R&D
Related docs
Get documents about "